1. Home
  2. CTMX vs EVTL Comparison

CTMX vs EVTL Comparison

Compare CTMX & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$4.84

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

N/A

Current Price

$3.98

Market Cap

607.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CTMX
EVTL
Founded
2008
2016
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
607.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CTMX
EVTL
Price
$4.84
$3.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$8.86
$13.20
AVG Volume (30 Days)
2.5M
786.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$138,103,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.58
N/A
Revenue Growth
36.45
N/A
52 Week Low
$0.40
$2.76
52 Week High
$6.35
$7.60

Technical Indicators

Market Signals
Indicator
CTMX
EVTL
Relative Strength Index (RSI) 43.68 37.32
Support Level $3.83 $3.71
Resistance Level $6.20 $4.70
Average True Range (ATR) 0.32 0.22
MACD -0.08 0.02
Stochastic Oscillator 16.01 11.46

Price Performance

Historical Comparison
CTMX
EVTL

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Share on Social Networks: